Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15CA063752-01
Application #
2105806
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1994-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost

  Institution

Name
University of North Dakota
Department
Pharmacology
Type
Schools of Medicine
DUNS #
102280781
City
Grand Forks
State
ND
Country
United States
Zip Code
58202

  Publications

Chen, Y; Yu, A; Saari, J T et al. (1997) Repression of hypoxia-reoxygenation injury in the catalase-overexpressing heart of transgenic mice. Proc Soc Exp Biol Med 216:112-6
Kang, Y J; Chen, Y; Yu, A et al. (1997) Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100:1501-6
Li, G; Chen, Y; Saari, J T et al. (1997) Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury. Am J Physiol 273:H1090-5
Kang, Y J; Chen, Y; Epstein, P N (1996) Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271:12610-6